GE Ventures and Stanford Health Care Partner On Digital Health Testing Lab

GE Ventures has partnered with Stanford Health Care (CA) to launch a new, independent business called Evidation Health. The company, backed with a $6.2 million Series A led by GE Ventures, is going to build a platform, initially at Stanford Health Care, where digital health products can be piloted and where both outcomes improvements and return on investment can be accurately measured. The team hopes that by offering this service to the digital health community startups will be able to pilot their products more efficiently, and will be able to walk away with more compelling results.

GE Ventures and Stanford Health Care Partner On Digital Health Testing Lab

Like most new businesses spun out of fortune 500 companies, Evidation Health is the byproduct of both acquisitions and mergers. The company’s roots can be traced back to a patient engagement startup called AchieveMint, an early Rock Health graduate. AchieveMint later changed its name to The Activity Exchange, and then merged with Evidation Health after GE Ventures became a majority shareholder. While GE Ventures will bring capital and access to entrepreneurs to the venture, and Stanford Health Care will bring a perpetual pilot site to the venture, The Activity Exchange is brining the technology to measure and quantify outcomes improvements. The company was founded by a data scientist with a background in healthcare and found a niche market consulting for pharmaceutical companies and payers interested in rolling out new digital support tools. To support this effort, and because it was being led by a data scientist, The Activity Exchange ended up building a an analytics platform that accurately measures engagement rates and outcomes improvements for digital health apps as they are deployed out in the field.

Read more...

Rock Health Backs Smoking Cessation Startup Chrono Therapeutics

Under its new business model as an early stage digital health investor, rather than purely an accelerator, Rock Health has invested $100,000 in smoking cessation startup Chrono Therapeutics. The new funding is a drop in the bucket for Chrono, which just closed a $32 million Series A this summer co-led by Canaan Partners and 5AM Ventures. However, startups have a history of pursuing Rock Health investments to gain access to its network of strategic mentors, and less for the actual capital infusion.

Rock Health Backs Smoking Cessation Startup Chrono Therapeutics

Chrono Therapeutics is building a smoking cessation platform and is using every facet of digital health to maximize the chances of success. The entire platform is centered around a wearable medical device that looks like a watch or an activity tracker. The device delivers nicotine to the wearer at key points throughout the day, strategically timed to mirror individual craving patterns and preempt them with nicotine. Researchers behind the startup suspect that by bringing a fully-automated nicotine delivery system to market, they can disrupt the nicotine gum and patch markets while also delivering a fundamentally more effective solution to smokers. The device has yet to prove itself in clinical trials, and FDA clearance is still years away, but Chrono hopes to have its smoking cessation wearable approved for sales and on shelves by 2017.

Read more...

Google Looks To Deep Learning To Ramp Up Pace Of Drug Discoveries

Google Research and Stanford University have co-published a paper describing how deep learning combined with a broad array of medical datasets could increase the pace of new drug discoveries.

Google Looks To Deep Learning To Ramp Up Pace Of Drug Discoveries

The paper, called “Large-Scale Machine Learning for Drug Discovery,” cites several early examples of pharmaceutical labs that have turned to deep learning neural networks to augment the cost-intensive and time-intensive processes that currently underpin drug discovery research. Currently, pharmaceutical companies start the research process by selecting a biomolecular target that the new drug will be designed to interact with. Next, tens of thousands of chemical compounds are created and tested to see what effect they have on the target. This process, known as high-throughput screening, can take years and cost millions of dollars depending on how difficult it is to isolate and measure the biomolecular target’s reaction. It is here that pharmaceutical companies have been experimenting with machine-learning systems as a potential substitute.

Read more...

Jawbone Partners With Huawei On Smartphone and Smartwatch Deal

The 2015 Mobile World Congress kicked off today in Barcelona and will run through the remainder of the week. The event kicked off with a roundtable keynote discussion on driving innovation in the mobile technology space, with Deutch Telekom CEO Tim Hottges, Vodafone CEO Vittorio Colao, Telenor president and CEO Jon Fredrik Baksaas, and Telefonica CEO Cesar Alierta. After the session, the exhibit floor opened and attendees were greeted by hundreds of consumer electronics manufacturers with new phones, tablets, announcements, and strategic partners to unveil.

Jawbone Partners With Huawei On Smartphone and Smartwatch Deal

Day one’s most interesting news includes Facebook CEO Mark Zuckerberg calling on cellular service providers to offer free low-bandwidth data plans to all customers, based on the idea that apps will drive higher data usage and convert free users into paying users. Google confirms that it will begin offering its own wireless service in the US, largely through partnerships with existing service providers. Samsung launches the Galaxy S6, the first major smartphone to include wireless charging technology. The new phone can reportedly bank four hours of battery life after just 10 minutes of wireless charging.  One other gadget turning heads at the MWC today is Huawei’s smartwatch.

Read more...

ChartSpan Raises $1.7 Million For Vendor Agnostic Patient Portal App

Greenville, SC-based digital health startup ChartSpan announces that it has raised a $1.7 million Series A, led by existing strategic investor Don Byrne, bringing the company’s total raised to $3 million since its 2012 launch. Byrne, himself a former healthcare startup founder, has led all of ChartSpan’s rounds thus far. Prior to ChartSpan, Byrne built an endoscopy startup called Byrne Medical that manufacturers disposable infection control products aimed at eliminating the need to sterilize some endoscopy equipment between uses. The company was acquired by Minntech in 2011 for $100 million.

ChartSpan Raises $1.7 Million For Vendor Agnostic Patient Portal App

With a committed investor behind it, ChartSpan is now working on a real problem in healthcare, the siloed state of patient portals. The Meaningful Use program mandated that all providers, hospitals, and practices, roll out patient portals so that patients would have online access to their medical records. As well intentioned as the requirement was, it has led to an environment in which every primary and secondary care setting a patient receives care in has a slice of the patient’s overall medical record stored on its patient portal. To date, there is no central, integrated place for a patient to see their full medical record online.

Read more...

Facebook Introduces New Suicide Prevention Tool During Its Annual Compassion Research Day

Facebook announces that it will be implementing new suicide prevention tools during a speech given at its fifth-annual Compassion Research Day this week. The Facebook team behind the enhancements has spent the past year working alongside mental health organizations Forefront, Now Matters Now, the National Suicide Prevention Lifeline, Save.org, and others to design a set of features that provides professional help to people that post concerning Facebook statuses, and provides tools for concerned friends to more accurately report the problem and get the right people engaged.

Facebook Introduces New Suicide Prevention Tool During Its Annual Compassion Research Day

The first new feature Facebook is rolling out is a new log-in screen for users who have had one of their posts reported as containing concerning language. When these user logs in, they are presented with options which include immediately being connected with a trained mental health professional from the National Suicide Prevention Lifeline, getting connected with online support groups and tools, or reviewing tips for how to cope with suicidal feelings.

Read more...

Digital Health Targets Counterfeit Drug Distributors

There is a perception within the health IT industry that innovation has passed over pharmacists. It’s a justifiable complaint, given that nurses, doctors, and therapists have all seen an abundance of new technologies developed and fielded over the last few years in hopes of improving their clinical effectiveness and efficiency. Pharmacists, on the other hand, are still largely using the same technologies that they were using before the HITECH Act and ACA sparked a digital health renaissance, verifying medication orders and managing drug inventories.

Digital Health Targets Counterfeit Drug Distributors

Until some brilliant entrepreneur comes up with the next disruptive idea for pharmacists, digital health startups have focused on other points in the medication lifecycle, such as improved drug reference libraries, medication adherence apps for consumers, and even ingestible digital medicines.  Among these startups working along the periphery of the pharmacy is TrackLink, a Wakefield, MA digital health startup that hopes to combat counterfeit drug sales by bringing digital medication tracking to the pharmaceutical industry. TrackLink CEO Shabbir Dahod estimates that 20-30 percent of the global medication supply chain is made up of counterfeit drugs that contain no active ingredient, a potentially dangerous problem for patients that are dependent on their medications.

Read more...

Atheer Raises $8.8 Million For Augmented Reality Glasses Designed For Doctors

While Google Glass has struggled to gain momentum within the consumer space, digital health startups have found a promising market for the devices in healthcare. Augmedix is building apps that navigate an EHR and document a physician encounter in real time by connecting a scribe via the glasses. Pristine.io is building technology to link doctors with EMTs, and surgeons with medical students. Now, a new startup is targeting healthcare with its own headset. Atheer announced that it has raised a $8.8 million venture capital round through undisclosed investors. The new funding follows the company’s June 2014 Series A in which it raised $1.5 million from Signatures Capital, and a February 2014 Indiegogo campaign that netted it $213,000.

Atheer Raises $8.8 Million For Augmented Reality Glasses Designed For Doctors

Atheer is building a headset that it hopes will be the first enterprise-friendly, augmented reality solution to come to market. Unlike Glass, Atheer is integrating data directly into the wearer’s field of view, and is designing a gesture-based user interface for wearers to interact with that data. Users can swipe in the air to scroll through an instruction manual, or can draw a square in the air to take an auto-focused photo. The headset runs an Android operating system, houses a Snapdragon 800 processor and, most importantly, looks like a relatively normal pair of glasses, when compared to others capable of delivering the same immersive set of features. Interestingly, the company is focused on enterprises, rather than consumers, for its product and has developed use cases for a variety of industries, including healthcare. The decision to stay away from consumers initially is likely a smart one. Consumers have been luke-warm about headset-based equipment but enterprises are much more open to the idea if it offers a fundamental improvement to their processes. Building an augmented reality business within the enterprise space first will give Atheer a captive base of end-users through which it can slowly improve the overall experience until it feels the device is ready for consumers.

Read more...
↑ Back to top

Founding Sponsors

Platinum Sponsors